SEER Q4 2023 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+8.3% YoY

Gross Profit

$2M41.7% margin

Operating Income

-$22M-531.9% margin

Net Income

-$18M-425.8% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+0.4%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$436M

Total Liabilities

$39M

Stockholders' Equity

$397M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+8.3%
Gross Profit	$2M	$2M	+12.4%
Operating Income	-$22M	-$25M	+10.9%
Net Income	-$18M	-$23M	+21.0%

Revenue Segments

Grant

$400,000100%